| 注册
首页|期刊导航|中国医药科学|补中益气丸治疗心血管疾病的临床证据评价与系统综述

补中益气丸治疗心血管疾病的临床证据评价与系统综述

刘洁 石兆峰 孙元隆 贾美君 赵哲俊 阮小芬

中国医药科学2025,Vol.15Issue(18):4-9,6.
中国医药科学2025,Vol.15Issue(18):4-9,6.DOI:10.20116/j.issn2095-0616.2025.18.01

补中益气丸治疗心血管疾病的临床证据评价与系统综述

Evaluation of clinical evidence and systematic review of Buzhong Yiqi Pill in the treatment of cardiovascular diseases

刘洁 1石兆峰 1孙元隆 1贾美君 1赵哲俊 2阮小芬2

作者信息

  • 1. 上海中医药大学附属曙光医院心血管科,上海 200021
  • 2. 上海中医药大学附属曙光医院心血管研究室,上海 201203
  • 折叠

摘要

Abstract

Objective To systematically evaluate the clinical efficacy evidence of Buzhong Yiqi Pill in the treatment of cardiovascular diseases.Methods Randomized controlled trials(RCTs)on Buzhong Yiqi Pill for cardiovascular diseases(coronary heart disease,hypotension,heart failure)were searched in databases including CNKI,Wanfang Data,VIP,SinoMed,PubMed,Embase,and Cochrane Library from inception to December 2024.Data were screened and extracted,literature quality was assessed using the Cochrane Risk of Bias Assessment Tool,and meta-analysis was performed using RevMan 5.4.Results A total of 15 RCTs involving 1442 patients were included.The meta-analysis revealed that in the coronary heart disease group:Buzhong Yiqi Pill significantly improved the effective rate of angina relief(RR=1.19,95%CI[1.03,1.38],P=0.02),enhanced electrocardiogram efficacy(RR=1.22,95%CI[1.10,1.34],P=0.0001),shortened the duration of ST-segment depression(MD=-23.81,95%CI[-35.17,-12.44],P<0.0001),reduced the frequency of ST-segment depression(MD=-2.81,95%CI[-5.46,-0.17],P=0.04),and decreased the incidence of complications(RR=0.43,95%CI[0.32,0.57],P<0.000 01).Hypotension group:Buzhong Yiqi Pill upright systolic blood pressure(MD=14.08,95%CI[9.25,18.90],P<0.000 01)and upright diastolic blood pressure(MD=11.48,95%CI[9.45,13.52],P<0.000 01)were significantly increased.Heart failure group:Buzhong Yiqi Pill significantly improved the clinical efficacy(RR=2.95,95%CI[1.08,8.06],P=0.03).Conclusion Buzhong Yiqi Pill can effectively improve angina symptoms,electrocardiogram outcomes,hypotension,and clinical efficacy in heart failure among patients with cardiovascular diseases,while reducing complications.This study provides clinical evidence for the use of Buzhong Yiqi Pill in treating cardiovascular diseases.

关键词

补中益气丸/系统评价/心血管疾病/临床证据评价

Key words

Buzhong Yiqi Pill/Systematic review/Cardiovascular disease/Clinical evidence evaluation

分类

医药卫生

引用本文复制引用

刘洁,石兆峰,孙元隆,贾美君,赵哲俊,阮小芬..补中益气丸治疗心血管疾病的临床证据评价与系统综述[J].中国医药科学,2025,15(18):4-9,6.

基金项目

国家自然科学基金(81403352) (81403352)

蒋梅先上海市名老中医学术经验研究工作室建设项目(SHGZS-202249) (SHGZS-202249)

上海中医药大学附属曙光医院"四明青年基金"(SGKJ-202102). (SGKJ-202102)

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文